It has been suggested that TNFα may also promote liver regeneration and that blocking TNFα may have adverse effects and may even exacerbate the disease [63], whereas our data suggest that at least in lean mice with MASLD a short-term diminishment of TNFα may have beneficial effects on the liver. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.